Skip to main content
. 2019 Feb 19;12:2632010X19829259. doi: 10.1177/2632010X19829259

Figure 1.

Figure 1.

Survival by therapy – Overall survival of patients according to the type of treatment. SSA indicates somatostatin analogues; Eve, everolimus; CT, chemotherapy. The mean Ki-67 labelling index of tumour metastases was 8.6% for SSA, 12.5% for Eve, and 28% for CT.